JAK2 and neoplasm: It has been shown that VEGF causes an increase in MDSCs and suppresses anti-tumor immune responses because VEGF expression over-activates Janus Kinases 2/Signal Transducer and Activator of Transcription 3 (Jak2/STAT3) signaling, leading to aberrant myeloid differentiation in tumors (36).